Analysts at Barclays assumed coverage on shares of Omega Healthcare Investors (NYSE:OHI – Get Free Report) in a note issued to investors on Tuesday,Benzinga reports. The brokerage set an “underweight” rating and a $51.00 price target on the real estate investment trust’s stock. Barclays‘s target price points to a potential upside of 4.08% from the stock’s current price.
A number of other research firms have also recently issued reports on OHI. Weiss Ratings raised Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a research note on Tuesday, June 30th. Raymond James Financial assumed coverage on Omega Healthcare Investors in a research report on Tuesday, June 16th. They set an “outperform” rating and a $50.00 price target on the stock. Truist Financial cut their price objective on Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating on the stock in a report on Tuesday, June 9th. Scotiabank decreased their price objective on Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Finally, Royal Bank Of Canada increased their target price on Omega Healthcare Investors from $47.00 to $48.00 and gave the stock a “sector perform” rating in a research note on Monday, May 4th. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Omega Healthcare Investors has an average rating of “Hold” and an average price target of $48.50.
Read Our Latest Stock Report on OHI
Omega Healthcare Investors Trading Down 0.8%
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The firm had revenue of $322.95 million during the quarter, compared to analyst estimates of $264.07 million. During the same period last year, the firm earned $0.75 EPS. Omega Healthcare Investors’s quarterly revenue was up 16.7% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Equities research analysts predict that Omega Healthcare Investors will post 3.1 EPS for the current year.
Institutional Investors Weigh In On Omega Healthcare Investors
Institutional investors have recently bought and sold shares of the company. State Street Corp grew its stake in shares of Omega Healthcare Investors by 4.8% during the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock worth $534,792,000 after acquiring an additional 671,473 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Omega Healthcare Investors by 9.4% in the fourth quarter. Geode Capital Management LLC now owns 8,515,924 shares of the real estate investment trust’s stock worth $377,648,000 after purchasing an additional 734,774 shares in the last quarter. Invesco Ltd. boosted its holdings in Omega Healthcare Investors by 8.6% during the fourth quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust’s stock worth $238,059,000 after purchasing an additional 424,024 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Omega Healthcare Investors by 4.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,463,838 shares of the real estate investment trust’s stock worth $197,927,000 after purchasing an additional 174,062 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its position in Omega Healthcare Investors by 18.5% in the fourth quarter. Bank of New York Mellon Corp now owns 4,457,975 shares of the real estate investment trust’s stock valued at $197,667,000 after purchasing an additional 696,759 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.
Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.
Featured Articles
- Five stocks we like better than Omega Healthcare Investors
- How TeraWulf’s Anthropic Deal Booted Up a $19B AI Empire
- Small-Cap ETFs Poised for Big Growth as Rate Outlook Shifts
- Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore
- As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
